IL1B and metabolic dysfunction-associated steatotic liver disease: It also raises a series of provocative questions about the cell-to-cell communication “in and outside” the liver in patients with NAFLD, suggesting that IL-1β could be a common trigger for both progression of liver disease and development of co-morbidities.